8th Annual Spring to Life


May 14-15, 2021

Proudly Hosted by New York Oncology Hematology, PC




  • This is a CME-Accredited Online LIVE Broadcast
  • Upon registration, confirmation will be provided via email
  • Login information and instructions will be emailed to you prior to the event

    Next quote »

    "Identification of molecular drivers has resulted in tailored treatments for our patients with non-small cell lung cancer which are not only more effective, but less toxic. It is essential the community oncologist have a keen knowledge of the most current precision testing techniques and incorporate newer therapies to provide state-of-the-art care to patients close to home."

    -Makenzi Evangelist, M.D., New York Oncology Hematology

    “The landscape of lung cancer with new biomarkers, immunotherapies, and targeted therapies is constantly evolving, and it is a challenge for the community oncologist to integrate and apply this new knowledge in daily clinical practice. Accessible continuing education forums are crucial to support this rapid evolution of cancer care."

    -Nischala Ammannagari, M.D., New York Oncology Hematology


    Please click here if you would like to be notified when registration is open. We hope to see you in 2020!
    S2L | Registration HCP

    Conference Platform

    The 2022 Spring to Life conference will be held April 29-30, 2022 and will be an online live broadcast utilizing a multimedia webcast and virtual conference platform to livestream the keynote, plenary sessions and ancillary events along with moderated Q&A panel discussions. The conference will be recorded and will be offered on-demand for 30 days following the live conference.


    The focus of the 2022 Spring to Life Conference is Gastrointestinal Cancers. New York Oncology Hematology (NYOH) has identified an ongoing unmet need for medical education in the area of hematologic malignancies. To meet this need, NYOH, in collaboration with The University of Chicago Pritzker School of Medicine, myMedEd, Inc., the American Cancer Society, and a panel of expert faculty from the academic, research, and community practice settings, developed an accredited, multi-supported, 2-day educational conference being held April 29-30, 2022 at spring2liferegistration.org. With an expanded agenda the conference is offering 8.0-hrs of continuing medical education. This is the ninth of these annual conferences that include programming for cancer clinicians.


    The purpose of this conference is to educate practitioners and update their knowledge of the biological pathways, diagnosis, current guidelines, and the existing and emerging therapies for the management of patients with gastrointestinal cancers.


    The target audience for this conference is the medical oncologist, hematologists, pathologists, oncology nurses, advanced practice providers, family practitioners, primary care practitioners, allied health professionals, and other providers with an interest in the care of patients with gastrointestinal cancers.


    After completing this activity, participants will be able to:

    • Evaluate the optimal perioperative treatment approaches in the management of gastrointestinal cancers.
    • Discuss updated data on novel agents and therapeutic approaches for patients with metastatic gastrointestinal cancers.
    • Analyze the role of molecular biomarkers and indicated testing strategies in the care of patients with gastrointestinal malignancies.
    • Discuss surgical management options of liver metastases in colorectal cancers and locoregionally advanced appendix cancer.
    • Understand the role and indications of Interventional Radiologic treatment modalities in gastrointestinal malignancies.

    This Activity Is Planned By myMedEd, Inc.

    Educational Partners

    Accredited Provider

    Accredited Provider
    Educational Partner
    Image Image

    This Activity Is Planned By myMedEd, Inc.